熱門資訊> 正文
MAIA Biotechnology宣布74万美元私募
2025-10-14 04:45
- MAIA Biotechnology (NYSE:MAIA) announced that it has entered into definitive agreements for the purchase and sale of an aggregate of 0.60M shares of common stock at a purchase price of $1.22 per share in a private placement offering gross proceeds of $0.74M to authorized investors.
- Each common share will be issued with a warrant to buy one share at a price of $1.52 per share, in line with the NYSE minimum price requirement.
- The net proceeds from the offering will be used to fund the execution of Step 1 of Part C of the Phase II trial THIO-101 and for working capital.
More on MAIA Biotechnology
- MAIA Biotechnology adopts crypto treasury strategy; shares up
- MAIA Biotechnology announces $2.25 million private placement
- Seeking Alpha’s Quant Rating on MAIA Biotechnology
- Historical earnings data for MAIA Biotechnology
- Financial information for MAIA Biotechnology
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
